Market Dynamics
The Middle East and Africa region is home to some of the fastest-growing economies in the world, and this increased economic growth will also lead to increased demand for Prothrombin Complex Concentrate (PCC), the clotting factor concentrate used to treat severe bleeding disorders. Increased demand for help with managing bleeding will further drive the regional PCC market. On the cost side, the accessibility of PCC in the Middle East and Africa region is aided by various government initiatives that have cut the cost of the product drastically, such as the Good Governance Initiative in Ethiopia and the Denapex Fund in Saudi Arabia. As healthcare services are becoming more affordable and more readily accessible in these regions, demand for PCC will increase. However, some areas in the region still suffer from inadequate healthcare infrastructure, such as the remote rural areas of Ethiopia. The availability of PCC, even in the areas where it is accessible, is often limited due to its expensive price. Furthermore, the treatment of bleeding disorders often requires the collaboration of multidisciplinary teams, such as hematologists, psychiatrists, and social workers, which puts an even bigger financial burden on families living in these regions.
To combat issues related to the accessibility and affordability of PCC, governments across the Middle East and Africa will have to take steps to increase awareness of bleeding disorders and provide more resources towards supporting care and management of patients affected by them. This could include providing access to comprehensive treatment protocols, in particular those that involve the use of PCC. Moreover, as the technology for PCC production advances, its cost is expected to decrease significantly in the near future, which will also help to increase availability and accessibility. To conclude, as the economic growth of the region increases, so too will the demand for Prothrombin Complex Concentrate. This is good news for the healthcare infrastructure of the Middle East and Africa region, as it will help to reduce fatalities associated with severe bleeding disorders. With the increased accessibility and affordability of PCC, more and more lives will be saved in the region in the coming years.
